These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26719671)

  • 1. The study on the preparation and characterization of gene-loaded immunomagnetic albumin nanospheres and their anti-cell proliferative effect combined with magnetic fluid hyperthermia on GLC-82 cells.
    Zhang H; Hou X; Lin M; Wang L; Li H; Yuan C; Liang C; Zhang J; Zhang D
    Drug Des Devel Ther; 2015; 9():6445-60. PubMed ID: 26719671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic albumin immuno-nanospheres as an efficient gene delivery system for a potential use in lung cancer: preparation, in vitro targeting and biological effect analysis.
    Hou X; Zhang H; Li H; Zhang D
    J Drug Target; 2016; 24(3):247-56. PubMed ID: 26325231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the combined treatment of lung cancer using gene-loaded immunomagnetic albumin nanospheres in vitro and in vivo.
    Zhang H; Liang C; Hou X; Wang L; Zhang D
    Int J Nanomedicine; 2016; 11():1039-50. PubMed ID: 27042059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GEM-loaded magnetic albumin nanospheres modified with cetuximab for simultaneous targeting, magnetic resonance imaging, and double-targeted thermochemotherapy of pancreatic cancer cells.
    Wang L; An Y; Yuan C; Zhang H; Liang C; Ding F; Gao Q; Zhang D
    Int J Nanomedicine; 2015; 10():2507-19. PubMed ID: 25848268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor-targeted ultra-small superparamagnetic iron oxide particles for magnetic resonance molecular imaging of lung cancer cells in vitro.
    Chen CL; Hu GY; Mei Q; Qiu H; Long GX; Hu GQ
    Chin Med J (Engl); 2012 Jul; 125(13):2322-8. PubMed ID: 22882856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of epidermal growth factor receptor-positive glioblastoma using lipid-encapsulated targeted superparamagnetic iron oxide nanoparticles in vitro.
    Chen HL; Hsu FT; Kao YJ; Liu HS; Huang WZ; Lu CF; Tsai PH; Ali AAA; Lee GA; Chen RJ; Chen CY
    J Nanobiotechnology; 2017 Nov; 15(1):86. PubMed ID: 29166921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced cytotoxic activity of cetuximab in EGFR-positive lung cancer by conjugating with gold nanoparticles.
    Qian Y; Qiu M; Wu Q; Tian Y; Zhang Y; Gu N; Li S; Xu L; Yin R
    Sci Rep; 2014 Dec; 4():7490. PubMed ID: 25502402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.
    Matar P; Rojo F; Cassia R; Moreno-Bueno G; Di Cosimo S; Tabernero J; Guzmán M; Rodriguez S; Arribas J; Palacios J; Baselga J
    Clin Cancer Res; 2004 Oct; 10(19):6487-501. PubMed ID: 15475436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.
    Huang S; Armstrong EA; Benavente S; Chinnaiyan P; Harari PM
    Cancer Res; 2004 Aug; 64(15):5355-62. PubMed ID: 15289342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific targeting of nasopharyngeal carcinoma cell line CNE1 by C225-conjugated ultrasmall superparamagnetic iron oxide particles with magnetic resonance imaging.
    Liu D; Chen C; Hu G; Mei Q; Qiu H; Long G; Hu G
    Acta Biochim Biophys Sin (Shanghai); 2011 Apr; 43(4):301-6. PubMed ID: 21345916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The therapeutic effect of PEI-Fe
    Zhang H; Li S; Chen F; Ma X; Liu M
    Front Oncol; 2023; 13():1080519. PubMed ID: 37091158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy.
    Tseng SH; Chou MY; Chu IM
    Int J Nanomedicine; 2015; 10():3663-85. PubMed ID: 26056447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of folic acid-conjugated, doxorubicin-loaded, magnetic bovine serum albumin nanospheres and their antitumor effects in vitro and in vivo.
    Yang R; An Y; Miao F; Li M; Liu P; Tang Q
    Int J Nanomedicine; 2014; 9():4231-43. PubMed ID: 25228802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
    Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
    Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.
    Raben D; Helfrich B; Chan DC; Ciardiello F; Zhao L; Franklin W; Barón AE; Zeng C; Johnson TK; Bunn PA
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):795-805. PubMed ID: 15701870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of non-small cell lung cancer (NSCLC) growth by a novel small molecular inhibitor of EGFR.
    Li J; Deng H; Hu M; Fang Y; Vaughn A; Cai X; Xu L; Wan W; Li Z; Chen S; Yang X; Wu S; Xiao J
    Oncotarget; 2015 Mar; 6(9):6749-61. PubMed ID: 25730907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of siRNAs targeting the EGFR T790M mutation in a non-small cell lung cancer cell line resistant to EGFR tyrosine kinase inhibitors and combination with various agents.
    Chen G; Kronenberger P; Teugels E; Umelo IA; De Grève J
    Biochem Biophys Res Commun; 2013 Feb; 431(3):623-9. PubMed ID: 23266614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of the Bcl-2 gene increases sensitivity to EGFR tyrosine kinase inhibitors in the H1975 lung cancer cell line harboring T790M mutation.
    Zou M; Xia S; Zhuang L; Han N; Chu Q; Chao T; Peng P; Chen Y; Gui Q; Yu S
    Int J Oncol; 2013 Jun; 42(6):2094-102. PubMed ID: 23588221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fe
    Lu Q; Dai X; Zhang P; Tan X; Zhong Y; Yao C; Song M; Song G; Zhang Z; Peng G; Guo Z; Ge Y; Zhang K; Li Y
    Int J Nanomedicine; 2018; 13():2491-2505. PubMed ID: 29719396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting EGFR-overexpressing tumor cells using Cetuximab-immunomicelles loaded with doxorubicin and superparamagnetic iron oxide.
    Liao C; Sun Q; Liang B; Shen J; Shuai X
    Eur J Radiol; 2011 Dec; 80(3):699-705. PubMed ID: 20810233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.